Update on Hodgkin Lymphoma. Since 2014.

Guest Editor: Andrea Gallamini

 

CURRENT ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION FOR RELAPSED AND REFRACTORY HODGKIN LYMPHOMA Luca Castagna, Carmelo Carlo-Stella, Rita Mazza, Armando Santoro | DOI: 10.4084/mjhid.2015.015

e2015015

 

PATHOBIOLOGY OF HODGKIN LYMPHOMA   Claudio Agostinelli, Stefano Pileri | DOI: 10.4084/mjhid.2014.040

e2014040

IMMUNOLOGICAL DEREGULATION IN HODGKIN’S DISEASE   Francesco Di Raimondo, Giorgio La Nasa | DOI: 10.4084/mjhid.2014.039

e2014039

EPIDEMIOLOGICAL OVERVIEW OF HODGKIN LYMPHOMA ACROSS THE MEDITERRANEAN BASIN   Massimiliano Salati, Marina Cesaretti, Matteo Macchia, Mufid El Mistiri, Massimo Federico | DOI: 10.4084/mjhid.2014.048

e2014048

PROGNOSTIC FACTORS IN HODGKIN LYMPHOMA   Annarosa Cuccaro, Francesca Bartolomei, Elisa Cupelli, Stefan Hohaus | DOI:10.4084/mjhid.2014.053

e2014053

THE EVOLVING ROLE OF RADIOTHERAPY IN EARLY STAGE HODGKIN’S LYMPHOMA   Umberto Ricardi, Andrea Riccardo Filippi, Cristina Piva, Pierfrancesco Franco | DOI:10.4084/mjhid.2014.035

e2014035

ADVANCED HODGKIN LYMPHOMA: A NEW ERA OF THERAPY   Eldad J Dann | DOI: 10.4084/mjhid.2014.063

e2014063

HODGKIN LYMPHOMA IN OLDER PATIENTS: AN ORPHAN DISEASE?   Antoine Thyss, Esma Saada, Lauris Gastaud, Frédéric Peyrade, Daniel Ré | DOI:10.4084/mjhid.2014.050

e2014050

 

CURRENT ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION FOR RELAPSED AND REFRACTORY HODGKIN LYMPHOMA   Luca Castagna, Carmelo Carlo-Stella, Rita Mazza, Armando Santoro | DOI:10.4084/mjhid.2015.015

e2015015